Hint mode is switched on Switch off

Terns Pharmaceuticals, ordinary share
TERN, US8808811074

FIND, SAVE & TRACK INVESTMENTS WITH CBONDS WATCHLIST

With Cbonds Watchlist you can always stay updated on your investments to make conscious decisions!

Watchlist
You need to request access
Add a stock to WL
Choose all Reset all
Terns Pharmaceuticals, сountry — USA
No trading data
Data display in a chart | table
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
No data
from
to
ADD-IN
Cbonds add-in API
bond data api
Authorization required
You need to request access
More than 2,500 records have been found, please specify your request
No data for the selected period
Welcome to Cbonds
New to Cbonds? · Take a 90-second tour of the platform.

Discover what you can do with Cbonds

Everything you need for fixed income research and monitoring.

  • 00:23 Coverage
  • 00:40 Bond screener
  • 00:54 Parameters
  • 01:10 Watchlist, Mobile app
  • 01:15 Excel Add-in
Get access Watch full tour

Latest quotes

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Analysts forecasts

  • median ***
  • average ***
  • min ***
  • max ***

Issuer

Profile
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule single- agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, or NASH, and other chronic liver diseases.
  • Issuer
  • Full borrower / issuer name
    Terns Pharmaceuticals Inc
  • Industry
    Pharmaceutical Preparation and Biotechnology

Placement data

  • Placement type
    IPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    TERN
  • Placement
    05.02.2021
  • Lock up period
    180
  • Number of papers
    7,500,000
  • Volume of raised funds
    127.5 mln USD
  • Placement share
    31.29%
  • Final placement price
    17 USD
  • Price change since placement date
    -100%
  • By capitalization
    407.52 mln USD
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    TERN
  • Placement
    12.08.2022
  • Lock up period
    180
  • Number of papers
    12,250,000
  • Volume of raised funds
    29.65 mln USD
  • Placement share
    32.57%
  • Final placement price
    2.42 USD
  • Price change since placement date
    -100%
  • By capitalization
    91.03 mln USD
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    TERN
  • Placement
    11.09.2024
  • Lock up period
    180
  • Number of papers
    11,919,048
  • Volume of raised funds
    125.15 mln USD
  • Placement share
    14.49%
  • Final placement price
    10.5 USD
  • Price change since placement date
    -100%
  • By capitalization
    863.67 mln USD
Other placements of the issuer Hide

IFRS/US GAAP reports

2025
I q eng
II q eng
III q eng
IV q eng
2024
I q eng
II q eng
III q eng
IV q eng
2023
I q eng
II q eng
III q eng
IV q eng
2022
I q eng
II q eng
III q eng
IV q eng
2021
I q eng
II q eng
III q eng
IV q eng
Show more Hide

Indicators

News

05/05/2026 Terns Pharmaceuticals: Completion Of Acquisition Or Disposition Of Assets, Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard; Transfer Of Listing, Material Modification To Rights Of Security Holders, Changes In Control Of Registrant, Departure Of Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers, Amendments To Articles Of Incorporation Or Bylaws; Change In Fiscal Year, Other Events, Financial Statements And Exhibits
24/03/2026 Terns Pharmaceuticals: Entry Into A Material Definitive Agreement, Regulation Fd Disclosure, Financial Statements And Exhibits
16/01/2026 Terns Pharmaceuticals: Entry Into A Material Definitive Agreement
21/10/2025 Terns Pharmaceuticals: Other Events, Financial Statements And Exhibits
11/06/2025 Terns Pharmaceuticals: Submission Of Matters To A Vote Of Security Holders
All organization news

Holders

Industry Leaders

Registration is required to get access.